# Mukta Arora

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mukta-arora/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,370 |
| Field | Hematopoietic Stem Cell Transplantation |
| h-index | 59 |
| i10-index | 167 |
| Last Known Institution | Kurukshetra University |
| OpenAlex ID | https://openalex.org/A5054714265 |
| ORCID iD | 0000-0001-9362-0556 |
| Works | 422 |

## Researcher papers

- [National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report](https://scholariq.org/papers/national-institutes-of-health-consensus-development-project-on-criteria-for/)
- [Current Use of and Trends in Hematopoietic Cell Transplantation in the United States](https://scholariq.org/papers/current-use-of-and-trends-in-hematopoietic-cell-transplantation-in-the-united/)
- [Risk factors for acute GVHD and survival after hematopoietic cell transplantation](https://scholariq.org/papers/risk-factors-for-acute-gvhd-and-survival-after-hematopoietic-cell/)
- [Ibrutinib for chronic graft-versus-host disease after failure of prior therapy](https://scholariq.org/papers/ibrutinib-for-chronic-graft-versus-host-disease-after-failure-of-prior-therapy/)
- [Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation](https://scholariq.org/papers/composite-end-point-of-graft-versus-host-disease-free-relapse-free-survival/)
- [Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research](https://scholariq.org/papers/increasing-incidence-of-chronic-graft-versus-host-disease-in-allogeneic/)
- [Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study](https://scholariq.org/papers/belumosudil-for-chronic-graft-versus-host-disease-after-2-or-more-prior-lines-of/)
- [A Refined Risk Score for Acute Graft-versus-Host Disease that Predicts Response to Initial Therapy, Survival, and Transplant-Related Mortality](https://scholariq.org/papers/a-refined-risk-score-for-acute-graft-versus-host-disease-that-predicts-response/)
- [Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study](https://scholariq.org/papers/impact-of-chronic-graft-versus-host-disease-on-the-health-status-of/)
- [Outcome of Transplantation for Myelofibrosis](https://scholariq.org/papers/outcome-of-transplantation-for-myelofibrosis/)
- [Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium](https://scholariq.org/papers/nonrelapse-mortality-among-patients-diagnosed-with-chronic-gvhd-an-updated/)
- [Convolutional Neural Network Based Maize Plant Disease Identification](https://scholariq.org/papers/convolutional-neural-network-based-maize-plant-disease-identification/)

## Researcher topics

- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Childhood Cancer Survivors' Quality of Life](https://scholariq.org/topics/childhood-cancer-survivors-quality-of-life/)

## Researcher university

- [Kurukshetra University](https://scholariq.org/institutions/kurukshetra-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.